Cough, Cold and Allergy (hay Fever) Remedies in Belgium

Publication Date	March 2009
Publisher	Euromonitor
Product Type	Report
Pages	45
ISBN Number	not applicable
Product Code	EUR00700

Buy this product or for assistance call +44 20 7060 7474

PDF £560.00$932 | €627

PRINT £560.00$932 | €627

FAX Order above formats by FAX

Summary

Euromonitor International's Cough, Cold and Allergy Products in Belgium report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data (2003-2008), allowing you to identify the sectors driving growth. It identifies the leading companies, the leading brands and offers strategic analysis of key factors influencing the market- be they new product developments, distribution or pricing issues. Forecasts to 2013 illustrate how the market is set to change. Product coverage: decongestants, cough remedies, pharyngeal preparations, medicated confectionery, combination products, child-specific products, antihistamines Data coverage: market sizes (historic and forecasts), company shares and brand shares Why buy this report? * Get a detailed picture of the cough, cold and allergy (hayfever) industry * Identify factors driving change * Understand the competitive environment, the markets major players and leading brands * Use five-year forecasts to assess how the market is predicted to develop Euromonitor International has over 30 years experience of publishing market research reports, business reference books and online information systems. With offices in London, Chicago, Singapore, Shanghai, Vilniuis, Dubai, Cape Town and Santiago and a network of over 600 analysts worldwide, Euromonitor International has a unique capability to develop reliable information resources to help drive informed strategic planning.

Content

Cough, Cold and Allergy (hay Fever) Remedies in Belgium
Euromonitor International
March 2009
Executive Summary
Disappointing Results in 2008 After Strong Growth in 2007
Manufacturers Focus on Leading Brands in Restrictive Environment
Market Still Fragmented, Despite Growing Global Consolidation
Pharmacies Still Monopolise Distribution, Despite Beginning of Deregulation
Rather Bleak Outlook in the Short Term
Key Trends and Developments
Bleak Prospects for Economy, Policy and Thus Purchasing Power
A More Favourable Environment for OTC Healthcare Despite Continuing Conservatism
Mixed Results for Segmentation
Consumer Lifestyles Impact OTC Formats
Related Markets Increasingly Overlap With OTC
Beginning of Deregulation and the Emergence of Internet Sales, But No Real Change in the Dominance of Chemists/pharmacies
Less Room To Manoeuvre for Smaller Players
Market Indicators
Market Data
$1OTC Registration and Classification
De-listing Or De-reimbursement
Advertising
Packaging and Labelling
Distribution
Vitamins and Dietary Supplements Registration and Classification
EU Legislation
Self-medication and Preventative Medicine
the Role Played by the Belgian Government
Trend Reversal Over the 2006-2008 Period
Alternative Therapy
Lobbying and Consumer Loyalty Ensure the Ongoing Success of Homeopathy
Other Alternative Therapies Impacted by Fashion
Generics
Switches
Definitions
Sources
Biodiphar NV SA
Strategic Direction
Key Facts
Company Background and Production
Competitive Positioning
Omega Pharma NV
Strategic Direction
Key Facts
Company Background
Production
Competitive Positioning
Patch Pharma SA
Strategic Direction
Key Facts
Company Background and Production
Competitive Positioning
Pharmaceutiques Trenker, Laboratoires
Strategic Direction
Key Facts
Company Background and Production
Competitive Positioning
Vemedia Pharma NV
Strategic Direction
Key Facts
Company Background
Production
Competitive Positioning
Headlines
Trends
Switches
Competitive Landscape
Prospects
Sector Data
List of Summaries
- Summary 1 Research Sources
- Summary 2 Biodiphar SA: Key Facts
- Summary 3 Biodiphar SA: Operational Indicators
- Summary 4 Biodiphar SA: Competitive Position 2008
- Summary 5 Omega Pharma NV: Key Facts
- Summary 6 Omega Pharma NV: Operational Indicators
- Summary 7 Omega Pharma NV: Production Statistics 2005
- Summary 8 Omega Pharma NV: Competitive Position 2008
- Summary 9 Patch Pharma NV SA: Key Facts
- Summary 10 Pharmaceutiques Trenker, Laboratoires: Key Facts
- Summary 11 Pharmaceutiques Trenker, Laboratoires: Operational Indicators
- Summary 12 Pharmaceutiques Trenker, Laboratoires: Competitive Position 2008
- Summary 13 Vemedia Pharma NV: Key Facts
- Summary 14 Vemedia Pharma NV: Production Statistics 2008
- Summary 15 Vemedia Pharma NV: Competitive Position 2008
List of Tables
- Table 1 Consumer Expenditure on Health Goods and Medical Services 2003-2008
- Table 2 Life Expectancy at Birth 2003-2008
- Table 3 Sales of OTC Healthcare by Sector: Value 2003-2008
- Table 4 Sales of OTC Healthcare by Sector: % Value Growth 2003-2008
- Table 5 OTC Healthcare Company Shares by Value 2004-2008
- Table 6 OTC Healthcare Brand Shares by Value 2005-2008
- Table 7 Penetration of Private Label by Sector 2003-2008
- Table 8 Sales of OTC Healthcare by Distribution Format: % Analysis 2003-2008
- Table 9 Sales of OTC Healthcare by Sector and Distribution Format: % Analysis 2008
- Table 10 Forecast Sales of OTC Healthcare by Sector: Value 2008-2013
- Table 11 Forecast Sales of OTC Healthcare by Sector: % Value Growth 2008-2013
- Table 12 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Subsector: Value 2003-2008
- Table 13 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Subsector: % Value Growth 2003-2008
- Table 14 Sales of Decongestants by Type: Value 2003-2008
- Table 15 Sales of Decongestants by Type: % Value Growth 2003-2008
- Table 16 Sales of Child-specific Cough, Cold and Allergy (Hay Fever) Remedies by Type: Value 2003-2008
- Table 17 Sales of Child-specific Cough, Cold and Allergy (Hay Fever) Remedies by Type: % Value Growth 2003-2008
- Table 18 Herbal vs Standard Cough, Cold and Allergy (Hay Fever) Remedies 2003-2008
- Table 19 Cough, Cold and Allergy (Hay Fever) Remedies Company Shares by Value 2004-2008
- Table 20 Cough, Cold and Allergy (Hay Fever) Remedies Brand Shares by Value 2005-2008
- Table 21 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Subsector: Value 2008-2013
- Table 22 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Subsector: % Value Growth 2008-2013